CHRS
Coherus Oncology, Inc. Common StockData: 2026-09-04
Quick Stats
Sep 04, 202652.7
AI Score
HOLD0.28
Volume Ratio
TBA
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
CHRS Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
CHRS Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
CHRS Options - Sort by Max open Interest (near term)
5th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CHRS Daily Out of Money Options - Sort by Max open Interest (near term)
5th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CHRS Daily In the Money Options - Sort by Max open Interest (near term)
5th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CHRS Most Active Options by Volume(near term)
5th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CHRS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CHRS Stock Summary
Last updated Sep 04, 2026
CHRS is currently trading at $1.42, positioned below its 200-day moving average of $1.57, suggesting bearish momentum. The stock has a 52-week range of $1.09 to $2.6158.
Technical Analysis: The 50-day moving average stands at $1.4, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 53.541, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.001, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates CHRS at 52.7/100 with a HOLD recommendation.
CHRS (Coherus Oncology, Inc. Common Stock) Indicators
Last updated Sep 04, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 53.541 |
| CMF (20) | 0.001 |
| ROC (10) | 0.704 |
| ADX (14) | 13.19 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.009 |
| AROONOSC (14) | 64.286 |
| WILLAMS %R (14) | -23.077 |
| MFI (14) | 68.3 |
Coherus Oncology, Inc. Common Stock is above the 50 Day SMA but below the 200 Day SMA — short-term strength within a longer-term downtrend (Mixed).
CHRS Moving Averages Analysis
Coherus Oncology, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Sep 04, 2026
CHRS (Coherus Oncology, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Sep 04, 2026
| Days | MA |
|---|---|
| 10 | 1.4 |
| 20 | 1.32 |
| 30 | 1.35 |
| 50 | 1.4 |
| 100 | 1.52 |
| 200 | 1.57 |
CHRS Fundamental Analysis
| P/E (Forward) | 41.1523 |
| P/E (Trailing) | -- |
| Market Cap ($) | 211.7 million |
| Earnings/Share ($) | -1.2 |
| Net Profit Margin (%) | -2.5941 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.855 |
| EPS Estimate Next Year ($) | -0.63 |
| WallStreet Target Price ($) | 7.75 |
| Most Recent Quarter |
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.